SecBot SecBot
144 ·Filed Nov 10, 2026

GMAB

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 11h ago SEC0001959173-26-007899
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to the company's market cap and the insider's likely total holdings. No material impact expected. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$54.07
T+0 close · Nov 10, 2026 · via day close
Latest settled
−0.37%
T+1 · $53.87
Vs SPY
−1.69%
α at T+1
Next horizon
T+5
in 7h
  1. T+0 · Nov 10 $54.07entry
  2. T+1 · 6d ago −0.37%α −1.69% · $53.87
  3. T+4 · todayOpen
  4. T+5 · in 7h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Judith V. Klimovsky, an officer of Genmab, filed a Form 144 notice of intent to sell 1,265 shares of common stock, with an estimated aggregate market value of approximately $704,327. The shares were acquired through stock awards in 2021 and 2023. The sale is relatively small relative to the company's $33.5B market cap and appears to be a routine insider transaction.

Key Facts

  • Insider Judith V. Klimovsky (Officer) filed Form 144 to sell 1,265 shares of Genmab common stock.
  • Estimated aggregate market value of the proposed sale is approximately $704,327.
  • Shares were acquired via stock awards on 01/06/2021 (365 shares) and 01/02/2023 (900 shares) as compensation.
  • The sale is planned for or around 11/10/2026.
  • The filing is an advance notice of intent to sell; the actual sale may not occur.

Financial Impact

Proposed sale of 1,265 shares valued at ~$704,327, representing less than 0.01% of Genmab's market cap.

dilution

Risk Factors

  • Insider sale may signal personal liquidity needs rather than a negative view on the company.
  • Form 144 is an intent to sell; the sale may not be completed.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007899
Document: 0001959173-26-007899-index.html0001959173-26-007899
Document: 0001959173-26-007899.txt0001959173-26-007899

Track record

31 reports on GMAB

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  3. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  4. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  5. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  6. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
  7. Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $54.07 Now $51.57 −4.62% settles Dec 9
  8. Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  9. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  10. Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
Showing 10 of 31

US Market Status

Market Closed · Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026